Five Oceans Advisors »

Regeneron Pharmaceuticals shares owned by Five Oceans Advisors

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Five Oceans Advisors from 13F filings

Historical chart of Five Oceans Advisors investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Five Oceans Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Five Oceans Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $271k 281 962.49
2023-12-31 $247k 281 878.29
2023-09-30 $237k 288 822.96
2023-06-30 $206k 286 718.54
2023-03-31 $240k 292 821.67

More positions owned by Five Oceans Advisors

Vanguard Scottsdale Fds Short Term Treas (VGSH)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Emerging Markets (DFSE)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Dimensional Etf Trust Inflation Prote (DFIP)
Apple (AAPL)
Dimensional Etf Trust Intl Core Equity (DFIC)
Microsoft Corporation (MSFT)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Dimensional Etf Trust International (DFSI)
Ishares Tr 0-3 Mnth Treasry (SGOV)
Vanguard Index Fds Total Stk Mkt (VTI)
Meta Platforms Cl A (META)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Novo-nordisk A S Adr (NVO)

View all positions for Five Oceans Advisors

Top funds holding Regeneron Pharmaceuticals

Vanguard Group
Jpmorgan Chase & Co
Dodge & Cox
Wellington Management Company
Norges Bank Investment Management
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
Citadel Advisors
Alliancebernstein
T. Rowe Price Associates
Ubs Global Asset Management Americas
Charles Schwab Investment Management
Dimensional Fund Advisors

View all funds holding Regeneron Pharmaceuticals